Special Diabetes Program Reauthorization Act of 2023

Bill 118 s 1855, also known as the Special Diabetes Program Reauthorization Act of 2023, is a piece of legislation currently being considered by the US Congress. The bill aims to reauthorize funding for the Special Diabetes Program (SDP), which provides critical support for research, prevention, and treatment of diabetes.

The SDP was initially established in 1997 to address the growing epidemic of diabetes in the United States. Since then, it has played a crucial role in funding research into new treatments and technologies for diabetes, as well as supporting programs aimed at preventing the disease and improving outcomes for those living with diabetes.

If passed, Bill 118 s 1855 would reauthorize funding for the SDP for an additional five years, ensuring that this important program can continue its vital work. The bill has received bipartisan support in Congress, with lawmakers from both parties recognizing the importance of addressing the diabetes epidemic in the United States. Overall, the Special Diabetes Program Reauthorization Act of 2023 is a crucial piece of legislation that has the potential to make a real difference in the lives of millions of Americans living with diabetes. It represents a bipartisan effort to support research, prevention, and treatment of diabetes, and deserves the support of Congress and the American people.